UK Archives - JAG Shaw Baker

InsightsIntellectual Property
June 12, 2018

What You Need To Know About Blockchain And The Law

Charlie Lyons-Rothbart takes a look at blockchain and the law. The global blockchain market is expected to be $7.59 billion by 2024. By the end of 2017, funding into blockchain…
Read More
InsightsLife SciencesUncategorized
May 4, 2018

Readying The Life Sciences Sector For GDPR

With the General Data Protection Regulation (GDPR) coming into effect on May 25, 2018, our IP Associate, Ashley Williams recently talked to Louise Fordham, editor of The Drugs & Dealers…
Read More
April 10, 2018

Client News: MediaGamma Closes £2 M Round

Rael Cline, Co-founder and CEO, MediaGamma Congrats to our client MediaGamma who closed a £2m round from the UCL Technology Fund in partnership with ParkWalk Advisors and the London Co-Investment…
Read More
Glowing Neon Sign on stonework wall
November 20, 2017

Our New Cambridge Office

We are very pleased to announce our new office in Cambridge. The office is part of our ongoing commitment to the Life Sciences ecosystem in the area and throughout the…
Read More
October 6, 2017

In Client News: Crane Venture Partners Leads $30 M Series C For AI Startup

Congratulations to our client, Crane Venture Partners on leading the Series C $30 Million funding round for London-based Onfido. Onfido uses artificial intelligence algorithms to help websites verify people’s identities by merely…
Read More
September 13, 2017

Bossa Raises $10 Million Series A For Its Simulation Game

Worlds Adrift (Image credit: Ofrat/Bossa) Summer turns to fall, and our clients continue to show no signs of stopping. In gaming news, we advised London-based Bossa Studios on its $10…
Read More
September 7, 2017

Habito Raises £18.5 Million In A Series B Round Led By Atomico

JAG Shaw Baker is proud to have advised our client Habito, on their £18.5 Million Series B round led by Atomico. The raise supports Habito, one of the standout ‘PropTech’ companies…
Read More
Life SciencesNews
May 19, 2017

Elasmogen Inks Research Agreement To Develop New Class Of Therapeutics

Congratulations to our client Elasmogen! Elasmogen, a spin-out from Aberdeen University, alongside Canada based Feldan Therapeutics, have announced a research agreement with Amgen to develop and deliver novel intracellular biologics.…
Read More
InsightsIntellectual Property
April 11, 2017

Fake News And Its Impact On Tech Companies

Recently, there have been rising concerns that the public is being deceived by the unprecedented dissemination of fake news on the internet and on social media, in particular. The term…
Read More
April 7, 2017

MyBuilder Acquired by HomeAdivsor

We ended March on a high note with some great M&A news for our client MyBuilder. The UK company was recently acquired by HomeAdvisor, an IAC company (NASDAQ: IAC) considered one of the largest home…
Read More

A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. more information

INFORMATION ABOUT OUR USE OF COOKIES Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience and also allows us to improve our website. By continuing to browse the website, you are agreeing to our use of cookies. A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. We use the following cookies: • Strictly necessary cookies. These are cookies that are required for the operation of our website. They include, for example, cookies that enable you to return to a previous page. • Analytical/performance cookies. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. This helps us to improve the way our website works, for example, by ensuring that users are finding what they are looking for easily. The analytical/performance cookies are provided on our behalf by Google Inc. to aid with reporting of user behaviour, market research and improving website functionality. This user behaviour is analysed in order to improve this website. To see how this applies to Google Analytics, visit http://www.google.co.uk/intl/en/analytics/privacyoverview.html. You can stop tracking by Google Analytics by visiting https://tools.google.com/dlpage/gaoptout?hl=en-GB. COOKIE DURATION The strictly necessary session cookies are a temporary cookie which remains in the cookie file of your browser until you close the browser. The other cookies will remain in the cookie file of your browser after the closing of the browser, and will become active again when you reopen this website. The different cookies have different expiration dates. Following expiry of a cookie, a new version of that cookie will be downloaded when you next visit this website, unless you have withdrawn your consent in the meantime. You can block cookies by activating the setting on your browser that allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or parts of our website. Contact If you have any queries regarding this cookie policy please contact us at info@jagshawbaker.com.